Healthy Adult Volunteer Study for Two Doses of a Shigella Vaccine

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04634513` - Shigella CVD 31000: Study of Responses With Shigella-ETEC Vaccine Strain CVD 1208S-122	Phase 1
Recruiting	`NCT04242264` - Phase 2 Shigella Vaccine and Challenge	Phase 2
Completed	`NCT01336699` - Safety and Immunogenicity of Two Live, Attenuated Oral Shigella Sonnei Vaccines: WRSs2 and WRSs3	Phase 1
Recruiting	`NCT04694235` - Egg Intervention During Pregnancy in Indonesia	N/A

See also

Status

Clinical Trial

Phase

Active, not recruiting

NCT04634513 - Shigella CVD 31000: Study of Responses With Shigella-ETEC Vaccine Strain CVD 1208S-122

Phase 1

Recruiting

NCT04242264 - Phase 2 Shigella Vaccine and Challenge

Phase 2

Completed

NCT01336699 - Safety and Immunogenicity of Two Live, Attenuated Oral Shigella Sonnei Vaccines: WRSs2 and WRSs3

Phase 1

Recruiting

NCT04694235 - Egg Intervention During Pregnancy in Indonesia

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT00210288
Study type	Interventional
Source	Institut Pasteur
Contact
Status	Completed
Phase	Phase 2
Start date	May 2005
Completion date	April 2007

Healthy Adult Volunteer Study for Two Doses of a Shigella Vaccine

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms